The updated guideline addresses rapid advances in pharmacologic management, balancing use of newer, older drugs.

Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

Across studies, CKD was consistently associated with elevated cardiovascular risk, even after adjustment for traditional ...

Carbohydrate control may be one dietary intervention to improve the TG/HDL ratio. Dyslipidemia often is a concern in patients with CKD because mortality in this population typically is the result of ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Well, the first step is diagnosis. We have ...

An eGFR of 30 classifies her as stage 4 CKD, with advanced renal disease. Her sCr alone would not accurately depict the severity of her kidney disease because of her dietary intake and lack of muscle ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

daily multivitamin does not reduce the risks of cvd in men Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be ...

New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a ...